Literature DB >> 15340835

A large MSH2 Alu insertion mutation causes HNPCC in a German kindred.

Matthias Kloor1, Christian Sutter, Nicolas Wentzensen, Friedrich W Cremer, Annick Buckowitz, Monika Keller, Magnus von Knebel Doeberitz, Johannes Gebert.   

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) syndrome is an autosomal, dominantly inherited disease accounting for about 1%-5% of all colorectal cancer cases. HNPCC predisposition is caused by germline mutations in at least five genes coding for DNA mismatch repair (MMR) proteins. More than 400 MMR gene mutations have been identified in HNPCC patients. About 90% of mutations affect the MLH1 and MSH2 genes. The mutational spectrum mainly includes point mutations and small deletions or insertions. Here, we report a large 184 base-pair Alu insertion mutation in exon 6 of the MSH2 gene in a German HNPCC family. The inserted sequence contains repetitive Alu sequence elements that present the highest homology with the old Alu J subfamily. The Alu J insertion was most likely derived from Alu-mediated recombination, since Alu J elements have been found close to the insertion site in adjacent introns, and since elements pivotal for Alu retrotransposition are missing. Our results suggest that the recombination event occurred at least one generation ago. This is the first report of an Alu insertion in the coding sequence of a MMR gene as the cause of HNPCC. Our data thus further extend the spectrum of MMR gene mutations causative for HNPCC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15340835     DOI: 10.1007/s00439-004-1176-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  31 in total

Review 1.  Testing guidelines for hereditary non-polyposis colorectal cancer.

Authors:  Asad Umar; John I Risinger; Ernest T Hawk; J Carl Barrett
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

Review 2.  Deficient DNA mismatch repair: a common etiologic factor for colon cancer.

Authors:  P Peltomäki
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

3.  Extensive somatic microsatellite mutations in normal human tissue.

Authors:  S Vilkki; J L Tsao; A Loukola; M Pöyhönen; O Vierimaa; R Herva; L A Aaltonen; D Shibata
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

4.  Chromosomal localization of the human heme oxygenase genes: heme oxygenase-1 (HMOX1) maps to chromosome 22q12 and heme oxygenase-2 (HMOX2) maps to chromosome 16p13.3.

Authors:  R K Kutty; G Kutty; I R Rodriguez; G J Chader; B Wiggert
Journal:  Genomics       Date:  1994-04       Impact factor: 5.736

Review 5.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

6.  An Alu-mediated rearrangement as cause of exon skipping in Hunter disease.

Authors:  Verena Ricci; Stefano Regis; Marco Di Duca; Mirella Filocamo
Journal:  Hum Genet       Date:  2003-02-11       Impact factor: 4.132

7.  Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations.

Authors:  R D Kolodner; N R Hall; J Lipford; M F Kane; M R Rao; P Morrison; L Wirth; P J Finan; J Burn; P Chapman
Journal:  Genomics       Date:  1994-12       Impact factor: 5.736

8.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

Authors:  R Fishel; M K Lescoe; M R Rao; N G Copeland; N A Jenkins; J Garber; M Kane; R Kolodner
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

9.  Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1.

Authors:  M D Ricciardone; T Ozçelik; B Cevher; H Ozdağ; M Tuncer; A Gürgey; O Uzunalimoğlu; H Cetinkaya; A Tanyeli; E Erken; M Oztürk
Journal:  Cancer Res       Date:  1999-01-15       Impact factor: 12.701

10.  Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas.

Authors:  W M Grady; A Rajput; L Myeroff; D F Liu; K Kwon; J Willis; S Markowitz
Journal:  Cancer Res       Date:  1998-07-15       Impact factor: 12.701

View more
  9 in total

1.  The Alu insertion in the CLCN5 gene of a patient with Dent's disease leads to exon 11 skipping.

Authors:  Félix Claverie-Martín; Carlos Flores; Montserrat Antón-Gamero; Hilaria González-Acosta; Víctor García-Nieto
Journal:  J Hum Genet       Date:  2005-07-23       Impact factor: 3.172

2.  Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.

Authors:  Caroline Goehringer; Christian Sutter; Matthias Kloor; Johannes Gebert; Emily P Slater; Monika Keller; Irmgard Treiber; Petra Ganschow; Martina Kadmon; Ute Moog
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

Review 3.  Roles for retrotransposon insertions in human disease.

Authors:  Dustin C Hancks; Haig H Kazazian
Journal:  Mob DNA       Date:  2016-05-06

4.  (Phospho)proteomic Profiling of Microsatellite Unstable CRC Cells Reveals Alterations in Nuclear Signaling and Cholesterol Metabolism Caused by Frameshift Mutation of NMD Regulator UPF3A.

Authors:  Malwina Michalak; Eva-Maria Katzenmaier; Nina Roeckel; Stefan M Woerner; Vera Fuchs; Uwe Warnken; Yan P Yuan; Peer Bork; Gabriele Neu-Yilik; Andreas Kulozik; Magnus von Knebel Doeberitz; Matthias Kloor; Jürgen Kopitz; Johannes Gebert
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

5.  High endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer.

Authors:  Pauline L Pfuderer; Alexej Ballhausen; Florian Seidler; Hans-Jürgen Stark; Niels Grabe; Ian M Frayling; Ann Ager; Magnus von Knebel Doeberitz; Matthias Kloor; Aysel Ahadova
Journal:  Br J Cancer       Date:  2019-07-30       Impact factor: 7.640

6.  A rare large duplication of MLH1 identified in Lynch syndrome.

Authors:  Abhishek Kumar; Nagarajan Paramasivam; Kari Hemminki; Asta Försti; Obul Reddy Bandapalli; Matthias Schlesner; Tianhui Chen; Rolf Sijmons; Dagmara Dymerska; Katarzyna Golebiewska; Magdalena Kuswik; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2021-01-19       Impact factor: 2.857

Review 7.  Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors.

Authors:  Julie Leclerc; Catherine Vermaut; Marie-Pierre Buisine
Journal:  Cancers (Basel)       Date:  2021-01-26       Impact factor: 6.639

8.  Extensive somatic L1 retrotransposition in colorectal tumors.

Authors:  Szilvia Solyom; Adam D Ewing; Eric P Rahrmann; Tara Doucet; Heather H Nelson; Michael B Burns; Reuben S Harris; David F Sigmon; Alex Casella; Bracha Erlanger; Sarah Wheelan; Kyle R Upton; Ruchi Shukla; Geoffrey J Faulkner; David A Largaespada; Haig H Kazazian
Journal:  Genome Res       Date:  2012-09-11       Impact factor: 9.043

9.  Contribution of large genomic rearrangements in Italian Lynch syndrome patients: characterization of a novel alu-mediated deletion.

Authors:  Francesca Duraturo; Angela Cavallo; Raffaella Liccardo; Bianca Cudia; Marina De Rosa; Giuseppe Diana; Paola Izzo
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.